Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-08-23
2011-08-23
Kemmerer, Elizabeth C (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S198100, C514S001100, C514S021300, C514S021400, C530S300000, C530S324000, C530S326000, C530S327000, C530S328000, C530S329000, C435S068100
Reexamination Certificate
active
08003108
ABSTRACT:
Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
REFERENCES:
patent: 4331647 (1982-05-01), Goldenberg
patent: 4376110 (1983-03-01), David et al.
patent: 4411993 (1983-10-01), Gillis
patent: 4427115 (1984-01-01), Laipply
patent: 4543439 (1985-09-01), Frackelton, Jr. et al.
patent: RE32011 (1985-10-01), Zimmerman et al.
patent: 4837440 (1989-06-01), Burtscher et al.
patent: 4902614 (1990-02-01), Wakabayashi et al.
patent: 5070108 (1991-12-01), Margolis
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5453492 (1995-09-01), Butzow et al.
patent: 5466468 (1995-11-01), Schneider et al.
patent: 5543158 (1996-08-01), Gref et al.
patent: 5552157 (1996-09-01), Yagi et al.
patent: 5565213 (1996-10-01), Nakamori et al.
patent: 5567434 (1996-10-01), Szoka, Jr.
patent: 5627052 (1997-05-01), Schrader et al.
patent: 5641515 (1997-06-01), Ramtoola et al.
patent: 5698426 (1997-12-01), Huse
patent: 5738868 (1998-04-01), Shinkarenko et al.
patent: 5780263 (1998-07-01), Hastings et al.
patent: 5795587 (1998-08-01), Gao et al.
patent: 5811238 (1998-09-01), Stemmer et al.
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5877397 (1999-03-01), Lonberg et al.
patent: 6054561 (2000-04-01), Ring
patent: 6057421 (2000-05-01), Muller et al.
patent: 6117911 (2000-09-01), Grainger et al.
patent: 6133426 (2000-10-01), Gonzalez et al.
patent: 6207153 (2001-03-01), Dan et al.
patent: 6395511 (2002-05-01), Brunkow et al.
patent: 6489445 (2002-12-01), Brunkow et al.
patent: 6495736 (2002-12-01), Brunkow et al.
patent: 6703199 (2004-03-01), Koide
patent: 6803453 (2004-10-01), Brunkow et al.
patent: 6806055 (2004-10-01), Berman et al.
patent: 6815201 (2004-11-01), Pinter
patent: 6818748 (2004-11-01), Fulton et al.
patent: 7192583 (2007-03-01), Brunkow et al.
patent: 2003/0165410 (2003-09-01), Taylor
patent: 2003/0186915 (2003-10-01), Pan et al.
patent: 2004/0009535 (2004-01-01), Brunkow et al.
patent: 2004/0023356 (2004-02-01), Krumlauf et al.
patent: 2004/0058321 (2004-03-01), Brunkow et al.
patent: 2004/0141875 (2004-07-01), Doshi
patent: 2004/0146888 (2004-07-01), Paszty et al.
patent: 2004/0158045 (2004-08-01), Brunkow et al.
patent: 2005/0106683 (2005-05-01), Winkler et al.
patent: 2005/0238646 (2005-10-01), Ledbetter et al.
patent: 2006/0233801 (2006-10-01), Brunkow et al.
patent: 2007/0292444 (2007-12-01), Krumlauf et al.
patent: 102 55 152 (2004-06-01), None
patent: 2 838 379 (2003-10-01), None
patent: 4-141095 (1992-05-01), None
patent: WO-91/13152 (1991-09-01), None
patent: WO-92/02551 (1992-02-01), None
patent: WO-92/06693 (1992-04-01), None
patent: WO-95/30003 (1995-11-01), None
patent: WO-98/21335 (1998-05-01), None
patent: WO-99/03996 (1999-01-01), None
patent: WO-99/06554 (1999-02-01), None
patent: WO-99/15556 (1999-04-01), None
patent: WO-00/32773 (2000-06-01), None
patent: WO-00/75317 (2000-12-01), None
patent: WO-01/64885 (2001-09-01), None
patent: WO-01/92308 (2001-12-01), None
patent: WO-01/98491 (2001-12-01), None
patent: WO-02/24888 (2002-03-01), None
patent: WO-2005/003158 (2005-01-01), None
patent: WO-2005/014650 (2005-02-01), None
Kirsch et al., EMBO J., 2000, 19(13):3314-3324.
Narayanan et al., Curr. Opin. Struct. Biol., 2009, vol. 19(2):156-163.
Alting-Mees et al., Strategies in Molecular Biology, 3:1-9 (1990).
Angal et al., Mol. Immunol., 30(1):105-108 (1993).
Avsian-Kretchmer et al., Molecular Endocrinology, 18(1):1-12 (2004).
Babcook et al., Proc. Natl. Acad. Sci. (USA), 93:7843-7848 (1996).
Baines et al., “Purification of Immunoglobulin G (IgG),” Methods in Molecular Biology, 10:79-104, The Humana Press, Inc. (1992).
Balemans et al., Hum. Mol. Genet., 10:537-543 (2001).
Bird et al., Science, 242:423-426 (1988).
Boemer et al., J. Immunol., 147:86-95 (1991).
Bowie et al., Science, 253:164-170 (1991).
Brenner et al., Curr. Op. Struct. Biol., 7(3):369-376 (1997).
Bruggemann et al., Curr. Opin. Biotechnol., 8:455-458 (1997).
Brunkow et al., Am. J. Hum. Genet., 68:577-589 (2001).
Burton et al., Adv. Immunol., 57:191-280 (1994).
Byrne et al., Gut, 54:78-86 (2005).
Chandran et al., Indian J. Exp. Biol., 35(8):801-809 (1997).
Chou et al., Adv. Enzymol. Relat. Areas Mol. Biol., 47:45-148 (1978).
Chou et al., Ann. Rev. Biochem., 47:251-276 (1979).
Clark, Immunology Today, 21(8):397-402 (2000).
Cormier, Curr. Opin. in Rheu., 7:243 (1995).
Couvreur et al., Crit. Rev. Ther. Drug Carrier Syst., 5(1):1-20 (1988).
Crameri et al., Nature, 391:288-291 (1998).
Dall'Acqua et al., Methods, 36(1):43-60 (2005).
Frost et al., Bone and Mineral, 18:227-236 (1992).
Glasky et al., Hybridoma, 8:377-389 (1989).
Green et al., Nature Genet., 7:13 (1994).
Gribskov et al., Meth. Enzym., 183:146-159 (1990).
Gribskov et al., Proc. Nat. Acad. Sci. (USA), 84(13):4355-4358 (1987).
Guinness-Hey, Metab. Bone Dis. Relat. Res., 5:177-181 (1984).
Harris, Journal of Chromatography, 705:129-134 (1995).
Hollinger et al., Nature Biotech., 23(9):1126-1136 (2005).
Holm et al., Nucl. Acid Res., 27(1):244-247 (1999).
Hoogenboom et al., J. Molec. Biol., 227:381-388 (1992).
Huse et al., Science, 246:1275-1281 (1989).
Hwang et al., Methods, 36(1):35-42 (2005).
Jakobovits et al., Ann. N.Y. Acad. Sci., 764:525-535 (1995).
Jee et al., J. Musculoskel. Neuron. Interact., 1:193-207 (2001).
Jones, Curr. Opin. Struct. Biol., 7(3):377-387 (1997).
Kabat et al., Sequences of Proteins of Immunological Interest, U.S. Department of Health and Human Services, NIH, USA (1987) (Table of Contents).
Kalu, Bone and Mineral, 15:175-192 (1991).
Kang et al., Proc. Natl. Acad. Sci. (USA), 88:4363-4366 (1991).
Khosla et al., Mayo Clin. Proc., 70:978-982 (1995).
Kohler et al., Nature, 256:495 (1975).
Kramer et al., Nucleic Acids Res., 12:9441 (1984).
Kunkel et al., Methods in Enzymol., 154:367-382 (1987).
Kunkel, Proc. Natl. Acad. Sci. (USA), 82:488-492 (1985).
Lasic, Trends Biotechnol., 16(7):307-321 (1998).
Lonberg et al., Nature, 368:856 (1994).
Low et al., J. Mol. Biol., 250:350-368 (1996).
Margalit, Crit. Rev. Ther. Drug Carrier Syst., 12(2-3):233-261 (1995).
Marks et al., Bio/Technology, 10:779-783 (1992).
Moult, Curr. Opin. Biotech., 7(4):422-427 (1996).
Nisonoff et al., Arch. Biochem. Biophys., 89:230-244 (1960).
Nygren et al., Curr. Opin. Struct. Biol., 7:463-469 (1997).
Patten et al., Curr. Opin. Biotechnol., 8:724-733 (1997).
Pluckthun et al., Methods Enzymol., 178:497-515 (1989).
Porter, Biochem. J., 73:119-126 (1959).
Quintanar-Guerrero et al., Drug Dev. Ind. Pharm., 24(12):1113-1128 (1998).
Riggs, West J. Med., 154:63-77 (1991).
Sanger et al., PNAS, 74:5463 (1997).
Sastry et al., Proc. Natl. Acad. Sci. (USA), 86:5728-5732 (1989).
Scatchard et al., Ann. N.Y. Acad. Sci., 51:660-672 (1949).
Schlebusch et al., Hybridoma, 16:47-52 (1997).
Sippl et al., Structure, 4(1):15-19 (1996).
Smith et al., J. Biol. Chem., 275:19992-20001 (2000).
Sudo et al., J. Cell Biol., 96:191-198 (1983).
Sutherland et al., Bone, 35:828-835 (2004).
Takakura, Nippon Rinsho, 56(3):691-695 (1998) (Abstract Only).
Taylor et al., Int. Immun., 6:579 (1994).
Thompson et al., J. Mol. Biol., 256:7-88 (1996).
Thornton et al., Nature, 354:105-106 (1991).
Warminton et al., J. Bone Mineral Res., 19:S56-S57 (2004).
Winter et al., Annu. Rev. Immunol., 12:433-455 (1994).
Wolff et al., Cancer Res., 53:2560-2565 (1993).
Yang et al., J. Mol. Biol., 254:392-403 (1995).
Zambaux et al., J. Controlled Release, 50(1-3):31-40 (1998).
Zhang et al., Molecular Immunology, 42(12):1445-1451 (2005).
zur Muhlen et al., Eur. J. Pharm. Biopharm., 45(2):149-155 (1998).
Eli Lilly Statement of Grounds of Appeal, Opposition to European Patent Application No. 1133558 B1, dated Sep. 28, 2009.
Declaration filed in connection with the European Patent EP 1133558 Opposition, Expert opinion of Prof. Dr. Thomas Muller, dated Sep. 23, 2009.
Winkler et al., Osteocyte control of bone formation via sclerostin, a novel BMP antagonist,EMBO J.22(23): 6267-
Henry Alistair James
Latham John
Lawson Alastair
Lu Hsieng Sen
Paszty Christpher
Amgen Inc.
Kemmerer Elizabeth C
Marshall & Gerstein & Borun LLP
UCB SA
Xie Xiaozhen
LandOfFree
Sclerostin epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sclerostin epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sclerostin epitopes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739290